BioPharma Credit PLC USDLSE: BPCP

BioPharma Credit PLC USD: Director Declaration

· Issued by BioPharma Credit PLC USD via RNS

Summary by 6ix AI

Nigel Reynolds, a Non-Executive Director of BioPharma Credit PLC, has been appointed as a Non-Executive Director of Patria Private Equity Trust Plc, with effect from November 17, 2026.

Key details

  • BioPharma Credit PLC made the disclosure under rule 6.4.9R(2) of the UK Listing Rules, which govern companies listed in the United Kingdom.

6ix AI wrote this summary from the release below and checked it against the release.

BioPharma Credit PLC
11 November 2026

11 November 2026

BIOPHARMA CREDIT PLC

(The "Company")

Director Declaration

BioPharma Credit Plc announces, in accordance with UKLR 6.4.9R(2), that Nigel Reynolds, Non-Executive Director of the Company, has been appointed as a Non-Executive Director of Patria Private Equity Trust Plc with effect from 17 November 2026.

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BioPharma Credit PLC USD on 6ix

Earlier from BioPharma Credit PLC USD

All BioPharma Credit PLC USD news releases